FIELD: chemistry.
SUBSTANCE: invention relates to the chemical and pharmaceutical industry and specifically to an agent which is 13-isopropyl-4,10-dimethyldodecahydro-13,16-epoxyoxireno[2,3]naphtho[2,1-d][1,2]dioxycin-4-carboxylic acid of formula: 
EFFECT: low toxicity, marked combination of anti-inflammatory and anti-ulcer activity.
1 cl, 1 ex, 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT IN FORM OF 8-(METHOXYCARBONYL)-4b,8-DIMETHYL-3-(2-METHYLPROPANOYL)-TETRADECAHYDROPHENANTHRENE-1,2,10a-TRICARBOXYLIC ACID AND PREPARATION METHOD THEREOF | 2009 |
|
RU2426720C1 |
| MEDICATION, REPRESENTING BETULIN BIS-ISONICOTINOATE, DEMONSTRATING ANTI-ULCER, ANTI-INFLAMMATORY AND HEPATOPROTECTIVE ACTIVITY | 2013 |
|
RU2538212C1 |
| METHOD FOR PREVENTION OF ULCERATION OF GASTRIC MUCOSA | 2020 |
|
RU2744455C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSA ULCERATION | 2011 |
|
RU2481111C1 |
| METHOD FOR PREVENTION OF ULTRA CASING ON GASTRIC MUCOSA | 2021 |
|
RU2759575C1 |
| METHOD FOR MAKING OZERO LECHEBNOYE MUD EXTRACT FOR ENHANCING ANTIINFLAMMATORY AND WOUND HEALING ACTION | 2010 |
|
RU2443425C1 |
| 4-(4-METHYLPHENYL)-4-OXO-2-[3-(ETHOXYCARBONYL-4,5-R,R-THIOPHEN-2-YLAMINO]BUT-2-ENOIC ACID, HAVING ANTI-INFLAMMATORY AND ANALGESIC ACTIVITY | 2008 |
|
RU2389724C1 |
| 3-[3-(MORPHOLINE-4-YL)PROPYL]-2-[(2,2,3-TRIMETHYLCYCLOPENT-3-ENE-1-YL)METHYL-1,3-THIAZOLIDINE-4-ONE WITH ANTI-ULCER AND ANTI-INFLAMMATORY ACTIVITY | 2017 |
|
RU2643669C1 |
| METHOD FOR PREVENTION OF GASTRIC MUCOSAL DAMAGE CAUSED BY ADMINISTRATION OF NONSTEROID ANTI-INFLAMMATORY AGENTS | 2010 |
|
RU2449784C1 |
| METHOD OF PREVENTING INJURY OF STOMACH MUCOSA CAUSED BY APPLICATION OF NON-STEROID ANTI-INFLAMMATORY MEDICATIONS | 2011 |
|
RU2455984C1 |
